beta

ZNTL

Zentalis Pharmaceuticals Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer

Market Cap: 1.03 Billion

Primary Exchange: NASDAQ

Website: zentalis.com

Shares Outstanding: 71 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.607413276195365

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 373 trading days

From: 2020-06-25 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud